Faculty

Professor Yuqin Song is a leading medical oncologist and hematologist, currently serving as Vice President of Peking University Cancer Hospital & Beijing Cancer Research Institute, and Deputy Director of the Lymphoma Department. She also oversees the GCP Office, Ethics Committee, and translational research initiatives.

Prof. Song specialises in the clinical diagnosis and treatment of lymphoma, with a strong focus on innovative therapies including BTK inhibitors, bispecific antibodies, PD-1 therapies, and CAR T-cell treatments. She has served as leading or co-leading principal investigator in over 200 clinical trials, contributing to the approval of 29 novel anti-lymphoma agents in China.

Her research interests include drug resistance mechanisms and translational oncology. She has authored over 100 publications in leading journals such as The Lancet Oncology, Blood, and JAMA.

Prof. Song also holds key leadership roles, including Chair of the Union for China Lymphoma Investigators.